Wild mushroom extracts as inhibitors of bacterial biofilm formation

Pathogens

Volumn 3, Issue 3, 2014, Pages 667-679

  Alves, Maria José ^a,b,c   Ferreira, Isabel C F R ^c   Lourenço, Inês ^c   Costa, Eduardo ^a   Martins, Anabela ^c   Pintado, Manuela ^a  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^b Centro Hospitalar de Trás os Montes e Alto Douro Unidade de Chaves   (Portugal)

^c INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

Author keywords

Biofilm; Clinical isolates; Cytotoxicity; Multi resistant; Wild mushroom extracts

Indexed keywords

AGARICUS BLAZEI EXTRACT; ELLIPTICINE; FISTULINA HEPATICA EXTRACT; FUNGAL EXTRACT; LEPISTA NUDA EXTRACT; LEUCOPAXILUS GIGANTEUS EXTRACT; METHANOL; MYCENA ROSEA EXTRACT; RUSSULA DELICA EXTRACT; SARCODON IMBRICATUS EXTRACT; UNCLASSIFIED DRUG; WATER;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; BIOFILM; CATHETER INFECTION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; ENDOCARDITIS; ESCHERICHIA COLI; GROWTH INHIBITION; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA;

EID: 84983285126     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens3030667     Document Type: Article

References (50)

1. Centers for Disease Control and Prevention (CDC). Epidemiological Report Reporting on 2011 Surveillance Data and 2012 Epidemic Intelligence Data; Centers Disease Control and Prevention: Atlanta, GA, USA, 2013; p. 199.
2. Akpaka, P.E.; Swanston, W.H.; Ihemere, H.N.; Correa, A.; Torres, J.A.; Tafur, J.D.; Montealegre, M.C.; Quinn, J.P.; Villegas, M.V. Emergence of KPC-producing Pseudomonas aeruginosa in Trinidad and Tobago. J. Clin. Microbiol. 2009, 47, 2670-2671.
3. Maki, D.G.; Masur, H.; McCormick, R.D.; Mermel, L.A.; Pearson, M.L.; Raad, I.I.; Randolph, A.; Weinstein, R.A. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. Morb. Mortal. Wkly. Rep. 2002, 9, 1-29.
4. Stahlhut, G.S.; Struve, C.; Krogfelt, A.K.; Reisner, A. Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol. Med. Microbiol. 2012, 65, 350-359.
5. Wasfi, R.; Abd El-Rahman, O.A.; Mansour, L.E.; Hanora, A.S.; Hashem, A.M.; Ashour, M.S. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Indian J. Med. Microbiol. 2012, 30, 76-80.
6. Foxman, B.; Wu, J.; Farrer, E.C.; Goldberg, D.E.; Younger, J.G.; Xi, C. Early development of bacterial community diversity in emergently placed urinary catheters. BMC Res. Notes 2012, 5, 332.
7. Al-Mathkhury, H.J.F.; Ali, A.S.; Ghafil, J.A. Antagonistic effect of bacteriocin against urinary catheter associated Pseudomonas aeruginosa biofilm. N. Am. J. Med. Sci. 2011, 3, 367-370.
8. Bonkat, G.; Widmer, A.F.; Rieken, M.; Merwe, A.; Braissant, O.; Müller, G.; Wyler, S.; Frei, R.; Gasser, T.C.; Bachmann, A. Microbial biofilm formation and catheter associated bacteriuria in patients with suprapubic catheterisation. World J. Urol. 2013, 31, 565-571.
9. Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284, 1318-1322.
10. Walker, J.T.; Marsh, P.D. A review of biofilms and their role in microbial contamination of dental unit water systems (DUWS). Int. Biodeterior. Biodegrad. 2004, 54, 87-98.
11. Branda, S.S.; Vik, S.; Friedman, L.; Kolter, R. Biofilms: The matrix revisited. Trends Microbiol. 2005, 13, 20-26.
12. Hall-Stoodley, L.; Stoodley, P. Evolving concepts in biofilm infections. Cell. Microbiol. 2009, 11, 1034-1043.
13. Flowers, R.H.K.J.; Schwenzer, R.F.; Kopel, M.J.; Fish, S.I.; Tucker, B.M. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized controlled trial. JAMA 1989, 261, 878-883.
14. Bach, A.H.; Eberhardt, A.; Frick, H.; Schmidt, B.W.; Bottinger; Martin, E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit. Care Med. 1999, 27, 515-520.
15. Donelli, G.; Francolini, I.; Piozzi, R.; di Rosa Marconi, W. New polymer-antibiotic systems to inhibit bacterial biofilm formation: A suitable approach to prevent central venous catheter-associated infections. J. Chemother. 2002, 14, 501-507.
16. Maki, D.G.S.M.; Stolz, S.J.; Wheeler, L.A.; Mermel, L.A. Prevention of central-venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann. Int. Med. 1997, 127, 257-266.
17. Marconi, W.A.; Galloppa, A.; Martinelli, A.; Piozzi, A. New polyurethane compositions able to bond high amounts of both albumin and heparin. II: Copolymers and polymer blends. Biomaterials 1996, 17, 1795-1802.
18. Marconi, W.I.; Francolini, A.; Piozzi di Rosa, R. Antibiotic releasing urethane polymers for prevention of catheter related infections. J. Bioact. Compat. Polym. 2001, 16, 393-407.
19. Raad, I.R.; Darouiche, R.; Hachem, M.; Mansouri, M.; Bodey, G.P. The broad-spectrum activity and efficacy of catheters coated with minocyclin and rifampin. J. Infect. Dis. 1996, 173, 418-424.
20. Schierholz, J.M.; Lucas, L.J.; Rump, A.; Pulverer, G. Efficacy of silver-coated medical devices. J. Hosp. Infect. 1998, 40, 257-262.
21. Sherertz, R.J.; Carruth, W.A.; Hampton, A.A.; Byron, M.P.; Solomon, D.D. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J. Infect. Dis. 1993, 167, 98-106.
22. Tebbs, S.E.; Elliott, T.S.J. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J. Antimicrob. Chemother. 1993, 31, 261-271.
23. Donelli, G.; Francolini, I. Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: Review. J. Chemother. 2001, 13, 595-606.
24. Harvey, A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov. Today 2000, 5, 294-300.
25. Turkoglu, A.; Duru, M.E.; Mercan, N.; Kivrak, I.; Gezer, K. Antioxidant and antimicrobial activities of Laetiporus sulphurous (Bull.) Murrill. Food Chem. 2007, 101, 267-273.
26. Gao, Y.H.; Tang, W.B.; Gao, H.; Chan, E.; Lan, J.; Li, X.; Zhou, S. Antimicrobial activity of the medicinal mushroom Ganoderma. Food Rev. Int. 2005, 21, 211-229.
27. Hatvani, N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int. J. Antimicrob. Agents 2001, 17, 71-74.
28. Alves, M.J.; Ferreira, I.C.F.R.; Martins, A.; Pintado, M. Antimicrobial activity of wild mushrooms extracts against clinical isolates resistant to different antibiotics. J. Appl. Microbiol. 2012, 113, 466-475.
29. Alves, M.J.; Ferreira, I.C.F.R.; Froufe, H.J.C.; Abreu, R.M.V.; Martins, A.; Pintado, M. Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies. J. Appl. Microbiol. 2013, 115, 346-357.
30. Jagani, S.; Chelikani, R.; Kim, D.-S. Effects of phenol and natural phenolic compounds on biofilm formation by Pseudomonas aeruginosa. Biofouling 2009, 25, 321-324.
31. Sokovic, M.; Ciric, A.; Glamoclija, J.; Nikolic, M.; van Griensven, J.L.D.L. Agaricus blazei hot water extract shows anti quorum sensing activity in the nosocomial human pathogen Pseudomonas aeruginosa. Molecules 2014, 19, 4189-4199.
32. Signoretto, C.; Marchi, A.; Bertoncelli, A.; Burlacchini, G.; Papetti, A.; Pruzzo, C.; Zaura, E.; Lingström, P.; Ofek, I.; Pratten, J.; et al. The anti-adhesive mode of action of a purified mushroom (Lentinus edodes) extract with anticaries and antigingivitis properties in two oral bacterial phatogens. BMC Complement. Altern. Med. 2014, 14, 75.
33. Francolini, I.; Norris, P.; Piozzi, A.; Donelli, G.; Stoodley, P. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob. Agents Chemother. 2004, 48, 4360-4365.
34. Hu, J.-F.; Garo, E.; Goering, M.G.; Pasmore, M.; Yoo, H-D.; Esser, T.; Sestrich, J.; Cremin, P.A.; Hough, G.W.; Perrone, P.; et al. Bacterial Biofilm Inhibitors from Diospyros dendo. J. Nat. Prod. 2006, 69, 118-120.
35. Borges, A.; Saavedra, M.J.; Simões, M. The activity of ferulic and gallic acids in biofilm prevention and controlo of pathogenic bacteria. Biofouling 2012, 7, 755-767.
36. Hancock, V.; Dahl, M.; Vejborg, R.M.; Klemm, P. Dietary plant components ellagic acid and tannic acid inhibit biofilm formation by E. coli. J. Med. Microbiol. 2010, 59, 496-498.
37. Vikram, A.; Jayaprakasha, G.K.; Jesudhasan, P.R.; Pillai, S.D.; Patil, B.S. Suppression of bacterial cell-cell signaling, biofilm formation and type III secretion system by citrus flavonoids. J. Appl. Microbiol. 2010, 109, 515-527.
38. Ferreira, I.; Barros, L.; Abreu, R. Antioxidants in wild mushroomns. Curr. Med. Chem. 2009, 12, 1543-1560.
39. Tunney, M.M.; Jones, D.S.; Gorman, S.P. Biofilm and biofilm-related encrustations of urinary tract devices. Methods Enzymol. 1999, 310, 558-566.
40. Huber, B.; Eberl, L.; Feucht, W.; Polster, J. Influence of polyphenols on bacterial biofilm formation and quorumsensing. Z. Naturforschung 2003, 58, 874-884.
41. Simoes, M.; Bennett, R.N.; Rosa, E.A. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilm. Nat. Prod. Rep. 2009, 26, 746-757.
42. Singh, B.N.; Singh, B.R.; Singh, R.L.; Prakash, D.; Dhakarec, R.; Upadhyay, G.; Singh, H.B. Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food Chem. Toxicol. 2009, 47, 1109-1116.
43. Barros, L.; Venturini, B.; Baptista, P.; Estevinho, L.; Ferreira, I.C.F.R. Chemical composition and biological properties of Portuguese wild mushrooms: A comprehensive study. J. Agric. Food Chem. 2008, 56, 3856-3862.
44. Barros, L.; Dueñas, M.; Ferreira, I.C.F.R.; Baptista, P.; Santos-Buelga, C. Phenolic acids determination by HPLC-DAD-ESI/MS in sixteen different Portuguese wild mushrooms species. Food Chem. Toxicol. 2009, 47, 1076-1079.
45. Heleno, S.A.; Barros, L.; Sousa, M.J.; Martins, A.; Ferreira, I.C.F.R. Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity. Food Chem. 2010, 119, 1443-1450.
46. Yaltirak, T.; Aslim, B.; Ozturk, S.; Alli, H. Antimicrobial and antioxidant activities of Russula delica. Food Chem. Toxicol. 2009, 47, 2052-2056.
47. Performance Standards for Antimicrobial Susceptibilitty Testing; CLSI Document M100-S18; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2008.
48. Comité de L'Antibiogramme De La Société Française de Microbiologie, Communiqué 2008 (Edition de Janvier 2008). Société Française de Microbiologie: Paris, France, 2008. (In French)
49. Stepanovic, S.; Vukovic, D.; Dakic, I.; Savic, B.; Švabic-Vlahovic, M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40, 175-179.
50. Abreu, R.M.V.; Ferreira, I.C.F.R.; Calhelha, R.C.; Lima, R.T.; Vasconcelos, M.H.; Adega, F.; Chaves, R.; Queiroz, M.J.R.P. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3 aminothieno[3,2-b]pyridine-2-carboxylate derivatives: In vitro evaluation, cell cycle analysisand QSAR studies. Eur. J. Med. Chem. 2011, 46, 5800-5806.